Corza Medical in the news
surgical community support provider
Tamtam found 14 recent articles about Corza Medical.
- EU Commission clears acquisition of Corza Medical’s biosurgery business unit by EFMS
The EU Commission approved EFMS's acquisition of Corza Medical's biosurgery unit, which includes fibrin sealants and surgical haemostatic products.
- Corza Medical Blade Acuity
Eyewire+ provides current ophthalmic field news from diverse sources.
- Corza Medical Expands Gut Suture Portfolio with over 40 New Codes
Corza Medical expanded its Gut suture portfolio with over 40 new codes, offering surgeons more sizes, needle combinations, and configurations to strengthen procedural coverage across specialties.
- Latham Watkins Advises EQT in Acquisition of TachoSil Biosurgery Business from Corza Medical
EQT is acquiring Corza Biosurgery, including the TachoSil product, from Corza Medical, with Latham & Watkins advising EQT.
- EQT To Acquire Corza Biosurgery And TachoSil To Expand Global Biosurgery Platform
EQT is set to acquire Corza Biosurgery and its TachoSil product from Corza Medical to establish a global biosurgery platform.
- EQT to buy biosurgery unit from GTCR’s Corza Medical
EQT is acquiring Corza Biosurgery, a medical patch business, from Corza Medical, marking a partial exit for GTCR.
- Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical
EQT X is set to acquire Corza Biosurgery, including the TachoSil biosurgery patch, from Corza Medical, with Latham & Watkins advising EQT.
- EQT to acquire the TachoSil® biosurgery business from Corza Medical
EQT will acquire Corza Biosurgery, including the TachoSil biosurgery business, from Corza Medical, planning to invest in its growth and market expansion.
- GTCR-backed Corza Medical to sell its biosurgery business unit to EQT
GTCR-backed Corza Medical is selling its biosurgery business unit, including the TachoSil product portfolio, to EQT.
- EQT To Acquire The Tachosil® Biosurgery Business From Corza Medical
EQT is set to acquire the TachoSil biosurgery business from Corza Medical.
- GTCR Announces Divestiture of Corza Medical's Biosurgery Business Unit to EQT
GTCR is selling Corza Medical's Biosurgery business to EQT, while Corza Medical will continue to focus on its remaining surgical technology businesses.
- GTCR to Sell Corza Medical's Biosurgery Business to EQT, Retains Core Surgical Technology Platform
GTCR is selling Corza Medical's Biosurgery business to EQT to refocus on its core surgical technology platform, while EQT gains the TachoSil product portfolio.
- Confluent Medical Technologies hires new chief operating officer
Confluent Medical Technologies hired former Corza Medical CEO and CFO Tom Testa as its new chief operating officer, overseeing global operations and driving growth.
- As Corza Medical takes aim at top device OEMs, new owners are likely on the horizon
Corza Medical is poised for new ownership as its private equity firm seeks to recapitalize, following substantial growth in its surgical tech business, particularly TachoSil, and strategic focus on customized client relationships and digital transformation.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Corza Medical?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies